This monkey business [Power / Sample Size]

posted by jag009  – NJ, 2013-06-13 23:42 (4756 d 00:41 ago) – Posting: # 10784
Views: 14,267

❝ ❝ […] Okay, it's from the 2001 guidance and RSABE was introduced much later...


❝ I think that’s the crucial point. At a Pharmaceutical Science Advisory Committee Meeting FDA suggested a minimum of 36 subjects and was voted down (have to dig out the reference). From what I’ve heard at conferences they want 24 – but I was never able to find a reference.


You mean this? Link

Given the fact that the CV>30%, do you think that it's possible for anyone(I mean would anyone dare to)try and pass a RSABE study with n=12? It's risky enough to run a regular submission BE study with n=12 already at CV<30%... I will go check with my professor and see (Dr.Endrenyi) when I go have dinner with him later... :-)

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
115 visitors (0 registered, 115 guests [including 18 identified bots]).
Forum time: 00:23 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5